ALC's Q4 EPS and revenues lag estimates, sending shares down 3%, even as sales increase 9% and 2026 guidance targets up to 7% ...

Feb 25 (Reuters) - Alcon on Tuesday forecast 2026 sales growth largely in line with market estimates and guided for a ...

ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the ...

For discussion purposes, our comments on growth rates are expressed in constant currency. Dave will then return with closing ...

Q4 2025 Management View CEO David Endicott emphasized that "the second half of 2025 and especially the fourth quarter demonstrated the strength and momentum of our business." He highlighted recent ...

It was business as usual for Alcon, the global eyecare company with manufacturing and research facilities in Berks County.

Total30 multifocal for astigmatism, a monthly toric lens for patients with presbyopia, is now available in the U.S., ...

Alcon (ALC) reported $2.7 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 9.1%. EPS of $0.78 for the same period compares to $0.72 a year ago. The ...

Alcon has revealed a new one-week replacement contact lens, Precision7, which will be commercially available in the UK and Ireland beginning in March 2026. The contact lens is described as offering “a ...

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...

SINKING SPRING, Pa. -- It was another steady quarterly report by Alcon, the Switzerland-based eyecare company with manufacturing and research facilities in Berks County. The company mostly beat ...